STRIVE
"STRIVE" is a word mark owned by Embecta Corp., filed at the USPTO on July 18, 2023. It has been allowed and covers class 10 (Medical Apparatus).
- Status
- Allowed
- Since April 28, 2026
- Filed
- July 18, 2023
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 98975541
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns STRIVE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Embecta Corp.
EMBC · Parsippany, United States
Representative
Stephen R. Baird
Greenberg Traurig, LLP
What the mark covers
The products and services STRIVE is filed for, grouped by Nice class.
Medical devices and apparatus in the field of diabetes, namely, medical devices and apparatus for measuring blood glucose levels and injecting insulin; Medical devices and medical apparatus in the field of diabetes, namely, medical devices for monitoring blood glucose levels and administering insulin therapy; Medical devices, namely, diabetes management devices in the nature of insulin pumps, blood glucose monitors, infusion pumps, infusion pump controllers and structural and replacement parts therefor; Medical devices and medical apparatus in the field of diabetes, namely, patch pumps for administering continuous subcutaneous insulin infusion for insulin therapy; Medical devices and medical apparatus in the field of diabetes, namely, wearable subcutaneous drug delivery devices, sold empty, in the nature of on-body injectors, insulin injectors, infusion pumps, insulin pumps, patch pumps, and controllers, and structural and replacement parts therefor; Medical venous access ports; lancets; needles for medical use; syringes for medical use; Pen needles used to deliver medications to manage diabetes; Infusion sets; Infusion pump accessories, namely, belt clips specifically designed for holding infusion pumps and infusion sets; Subcutaneous infusion sets for use by diabetes patients in connection with insulin pumps; Infusion pumps; Insulin pumps; Infusion and insulin pump accessories, namely, medical sensors, meters, and medical devices for measuring and monitoring blood and urine properties; Medical devices and medical apparatus for measuring and monitoring blood and urine properties; Glucose meters; Blood glucose meters; Medical apparatus for monitoring blood glucose levels; Medical apparatus and instruments for monitoring glucose; Continuous glucose monitoring systems comprised of a medical apparatus for monitoring glucose; Sensor-based glucose monitors for medical purposes; Blood glucose monitoring systems, namely, blood glucose monitors, and parts and accessories therefor, namely, blood glucose monitoring carrying cases, and electronic blood glucose test diaries in the nature of integrated computer memory devices within blood glucose monitors; Devices for monitoring blood glucose for medical purposes; Devices for measuring blood sugar; Medical devices, namely, medical sensors that are implanted and inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, data receivers, sensor housings and sensor insertion devices; Medical diagnostic apparatus for testing blood sugar levels incorporating recorded software for the collection, editing, organizing, modifying, transmission, storage and sharing of medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for controlling and managing patient medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for acquiring, analyzing, transmitting and storing medical and physiological data; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for linking medical instruments and devices for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for providing nonmedical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of blood glucose monitors incorporating computer hardware and recorded software for monitoring blood glucose in connection with blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of insulin pumps incorporating computer hardware and recorded software for controlling insulin delivery in connection with insulin pumps; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps, and blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for obtaining, controlling, and managing patient medical information on wearable medical devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software for controlling and managing wearable insulin delivery devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices in the nature of infusion pumps, insulin pumps, and blood glucose monitors incorporating computer hardware and recorded software used to display, manage, and monitor diabetes management information
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
- Notification of examiners amendment e-mailed
- Examiners amendment e-mailed
- Examiners amendment -written
- Previous allowance count withdrawn
10 earlier steps on the official record.
About STRIVE
Who owns the trademark "STRIVE"?
The USPTO trademark "STRIVE" (application 98975541) is owned by Embecta Corp.
What is the status of "STRIVE"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull STRIVE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a59-f59f-7399-9ff7-3bf4feb0da81
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a59-f59f-7399-9ff7-3bf4feb0da81",
"object": "trademark",
"mark_text": "STRIVE",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "98975541",
"filing_date": "2023-07-18",
"nice_classes": [
10
],
"owners": [
{
"name": "Embecta Corp.",
"entity_id": "ent_019f286b-e289-72ae-8107-4fda2e6cb481"
}
]
}